Orgenesis Inc. (ORGS)
ORGS Stock Price Chart
Explore Orgenesis Inc. interactive price chart. Choose custom timeframes to analyze ORGS price movements and trends.
ORGS Company Profile
Discover essential business fundamentals and corporate details for Orgenesis Inc. (ORGS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
13 Mar 2012
Employees
146.00
Website
https://www.orgenesis.comCEO
Vered Caplan
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
ORGS Financial Timeline
Browse a chronological timeline of Orgenesis Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Nov 2025
Earnings released on 6 Aug 2025
Earnings released on 15 May 2025
Earnings released on 22 Apr 2025
Earnings released on 13 Nov 2024
EPS came in at -$1.93 , while revenue for the quarter reached $347.00K .
Stock split effective on 25 Sept 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 Aug 2024
EPS came in at -$2.30 falling short of the estimated $1.40 by -264.29%, while revenue for the quarter reached $246.00K , beating expectations by +49.09%.
Earnings released on 21 May 2024
EPS came in at -$2.90 falling short of the estimated $1.80 by -261.11%, while revenue for the quarter reached $141.00K , missing expectations by -14.55%.
Earnings released on 19 Mar 2024
EPS came in at -$1.09 falling short of the estimated $0.18 by -703.39%, while revenue for the quarter reached -$13.60M , missing expectations by -170.83%.
Earnings released on 13 Nov 2023
EPS came in at -$4.30 falling short of the estimated $0.10 by -4.40K%, while revenue for the quarter reached $110.00K , missing expectations by -99.43%.
Earnings released on 11 Aug 2023
EPS came in at -$1.50 falling short of the estimated $0.06 by -2.60K%, while revenue for the quarter reached $6.98M , missing expectations by -34.81%.
Earnings released on 10 May 2023
EPS came in at -$1.70 falling short of the estimated $0.05 by -3.50K%, while revenue for the quarter reached $7.04M , missing expectations by -34.17%.
Earnings released on 21 Mar 2023
EPS came in at -$1.60 , while revenue for the quarter reached $13.62M , beating expectations by +64.14%.
Earnings released on 10 Nov 2022
EPS came in at -$0.50 falling short of the estimated -$0.20 by -150.00%, while revenue for the quarter reached $7.99M , beating expectations by +9.42%.
Earnings released on 16 Aug 2022
EPS came in at -$2.20 falling short of the estimated -$0.20 by -1.00K%, while revenue for the quarter reached $7.20M , beating expectations by +2.87%.
Earnings released on 23 May 2022
EPS came in at -$1.60 falling short of the estimated -$0.40 by -300.00%, while revenue for the quarter reached $7.21M , beating expectations by +14.48%.
Earnings released on 30 Mar 2022
EPS came in at -$2.00 falling short of the estimated -$0.06 by -3.23K%, while revenue for the quarter reached $6.89M , missing expectations by -23.42%.
Earnings released on 4 Nov 2021
EPS came in at $4.20 surpassing the estimated -$0.35 by +1.30K%, while revenue for the quarter reached $8.68M , missing expectations by -3.60%.
Earnings released on 5 Aug 2021
EPS came in at $1.10 surpassing the estimated -$0.23 by +578.26%, while revenue for the quarter reached $10.55M , beating expectations by +219.55%.
Earnings released on 7 May 2021
EPS came in at -$0.10 surpassing the estimated -$0.26 by +61.54%, while revenue for the quarter reached $9.39M , missing expectations by -45.49%.
Earnings released on 9 Mar 2021
EPS came in at -$2.34 , while revenue for the quarter reached $2.30M .
Earnings released on 5 Nov 2020
EPS came in at -$0.11 , while revenue for the quarter reached $1.73M .
ORGS Stock Performance
Access detailed ORGS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.